Cormorant Asset Management, LP Diversified Active

CIK: 0001583977 · Show all filings

Period: Q2 2015 (← Previous) (Next →)

Filing Date: Aug 14, 2015

Total Value ($000): $752,151 (100.0% shares, 0.0% debt)

Holdings (80)

ALKS ALKERMES PLC 6.0%
Value ($000) $45,038 Shares 700,000 Est. Cost $56.67 Unrealized +8.0%
HRTX HERON THERAPEUTICS INC 6.0%
Value ($000) $44,870 Shares 1,440,000 Est. Cost $12.49 Unrealized +50.6%
RECEPTOS INC 5.6%
Value ($000) $41,811 Shares 220,000 Est. Cost $43.18 Unrealized
ALDER BIOPHARMACEUTICALS INC 5.3%
Value ($000) $40,123 Shares 757,475 Est. Cost $41.16 Unrealized
DYAX CORP 4.9%
Value ($000) $37,100 Shares 1,400,000 Est. Cost $11.07 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 4.6%
Value ($000) $34,335 Shares 718,900 Est. Cost $15.30 Unrealized +177.2%
SRNE SORRENTO THERAPEUTICS INC 4.6%
Value ($000) $34,277 Shares 1,945,334 Est. Cost $8.64 Unrealized +48.8%
EGRX EAGLE PHARMACEUTICALS INC 3.2%
Value ($000) $24,258 Shares 300,000 Est. Cost $20.11 Unrealized +223.9%
ARDX ARDELYX INC 3.1%
Value ($000) $23,653 Shares 1,481,075 Est. Cost $17.63 Unrealized -28.5%
PORTOLA PHARMACEUTICALS INC 3.0%
Value ($000) $22,775 Shares 500,000 Est. Cost $27.49 Unrealized
NOVAVAX INC 2.4%
Value ($000) $17,824 Shares 1,600,000 Est. Cost $6.35 Unrealized
TESARO INC 2.3%
Value ($000) $17,123 Shares 291,250 Est. Cost $38.73 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 2.2%
Value ($000) $16,782 Shares 140,000 Est. Cost $119.50 Unrealized 0.0%
QUOTIENT LTD 2.2%
Value ($000) $16,551 Shares 1,119,100 Est. Cost $13.68 Unrealized
CHRS COHERUS BIOSCIENCES INC 2.2%
Value ($000) $16,448 Shares 569,130 Est. Cost $20.98 Unrealized +20.5%
ADVAXIS INC 2.2%
Value ($000) $16,264 Shares 800,000 Est. Cost $7.24 Unrealized
AGENUS INC 1.8%
Value ($000) $13,454 Shares 1,559,000 Est. Cost $4.54 Unrealized
CHINA BIOLOGIC PRODS INC 1.7%
Value ($000) $12,840 Shares 111,500 Est. Cost $66.66 Unrealized
DXCM DEXCOM INC 1.6%
Value ($000) $12,237 Shares 153,000 Est. Cost $7.91 Unrealized +121.9%
PFENEX INC 1.6%
Value ($000) $12,123 Shares 624,900 Est. Cost $16.77 Unrealized
DYNAVAX TECHNOLOGIES CORP 1.6%
Value ($000) $11,713 Shares 500,000 Est. Cost $23.43 Unrealized
NEVRO CORP 1.5%
Value ($000) $11,207 Shares 208,500 Est. Cost $53.14 Unrealized
RARE ULTRAGENYX PHARMACEUTICAL IN 1.4%
Value ($000) $10,444 Shares 102,000 Est. Cost $46.32 Unrealized +67.6%
BCRX BIOCRYST PHARMACEUTICALS 1.3%
Value ($000) $10,152 Shares 680,000 Est. Cost $9.67 Unrealized +17.6%
RECRO PHARMA INC 1.3%
Value ($000) $10,078 Shares 780,000 Est. Cost $7.16 Unrealized
REGULUS THERAPEUTICS INC 1.3%
Value ($000) $9,826 Shares 896,522 Est. Cost $14.62 Unrealized
FORWARD PHARMA A/S 1.3%
Value ($000) $9,703 Shares 255,000 Est. Cost $23.92 Unrealized
CURIS INC 1.2%
Value ($000) $8,712 Shares 2,632,000 Est. Cost $2.28 Unrealized
KERYX BIOPHARMACEUTICALS INC 1.1%
Value ($000) $8,243 Shares 826,000 Est. Cost $13.75 Unrealized
KARYOPHARM THERAPEUTICS INC 1.1%
Value ($000) $8,190 Shares 300,987 Est. Cost $33.09 Unrealized
COLL COLLEGIUM PHARMACEUTICAL INC 1.1%
Value ($000) $8,028 Shares 450,000 Est. Cost $17.29 Unrealized 0.0%
OVASCIENCE INC 1.0%
Value ($000) $7,296 Shares 252,180 Est. Cost $25.13 Unrealized
OMER OMEROS CORP 0.9%
Value ($000) $6,989 Shares 388,500 Est. Cost $12.81 Unrealized +68.5%
MINERVA NEUROSCIENCES INC 0.9%
Value ($000) $6,641 Shares 1,145,053 Est. Cost $5.16 Unrealized
EPIZYME INC 0.8%
Value ($000) $6,390 Shares 266,250 Est. Cost $18.78 Unrealized
ACCELERON PHARMA INC 0.8%
Value ($000) $6,328 Shares 200,000 Est. Cost $32.04 Unrealized
ARRAY BIOPHARMA INC 0.8%
Value ($000) $6,129 Shares 850,000 Est. Cost $5.01 Unrealized
LIPOCINE INC NEW 0.8%
Value ($000) $5,720 Shares 666,666 Est. Cost $6.90 Unrealized
APTOSE BIOSCIENCES INC 0.7%
Value ($000) $5,542 Shares 1,081,867 Est. Cost $5.91 Unrealized
ROCKWELL MEDICAL INC 0.7%
Value ($000) $5,481 Shares 340,000 Est. Cost $12.66 Unrealized
EPIRUS BIOPHARMACEUTICALS IN 0.7%
Value ($000) $5,120 Shares 896,600 Est. Cost $8.68 Unrealized
NEKTAR THERAPEUTICS 0.7%
Value ($000) $4,973 Shares 397,500 Est. Cost $12.07 Unrealized
LION BIOTECHNOLOGIES INC 0.6%
Value ($000) $4,583 Shares 499,815 Est. Cost $11.67 Unrealized
KITE PHARMA INC 0.6%
Value ($000) $4,195 Shares 68,800 Est. Cost $46.23 Unrealized
SGMO SANGAMO BIOSCIENCES INC 0.5%
Value ($000) $4,003 Shares 361,000 Est. Cost $17.13 Unrealized -24.7%
IMMUNE DESIGN CORP 0.5%
Value ($000) $3,903 Shares 189,000 Est. Cost $18.77 Unrealized
CELYAD SA 0.5%
Value ($000) $3,902 Shares 75,000 Est. Cost $52.03 Unrealized
GLYCOMIMETICS INC 0.5%
Value ($000) $3,649 Shares 458,955 Est. Cost $16.33 Unrealized
ACELRX PHARMACEUTICALS INC 0.5%
Value ($000) $3,604 Shares 850,000 Est. Cost $9.56 Unrealized
DICERNA PHARMACEUTICALS INC 0.5%
Value ($000) $3,418 Shares 245,000 Est. Cost $15.70 Unrealized
DERMIRA INC 0.4%
Value ($000) $2,984 Shares 170,000 Est. Cost $18.11 Unrealized
TETRALOGIC PHARMACEUTICAL C 0.4%
Value ($000) $2,978 Shares 5,000,000 Est. Cost $0.60 Unrealized
FOLD AMICUS THERAPEUTICS INC 0.4%
Value ($000) $2,830 Shares 200,000 Est. Cost $12.02 Unrealized 0.0%
AVEO PHARMACEUTICALS INC 0.4%
Value ($000) $2,763 Shares 1,587,715 Est. Cost $1.74 Unrealized
BLUEPRINT MEDICINES CORP 0.4%
Value ($000) $2,649 Shares 100,000 Est. Cost $26.49 Unrealized
ATARA BIOTHERAPEUTICS INC 0.4%
Value ($000) $2,638 Shares 50,000 Est. Cost $52.76 Unrealized
VERSARTIS INC 0.3%
Value ($000) $2,587 Shares 170,000 Est. Cost $28.04 Unrealized
CERULEAN PHARMA INC 0.3%
Value ($000) $2,536 Shares 551,354 Est. Cost $5.47 Unrealized
GENVEC INC 0.3%
Value ($000) $2,400 Shares 1,176,235 Est. Cost $2.65 Unrealized
HTG MOLECULAR DIAGNOSTICS IN 0.3%
Value ($000) $2,241 Shares 201,000 Est. Cost $11.15 Unrealized
KINDRED BIOSCIENCES INC 0.3%
Value ($000) $2,240 Shares 328,497 Est. Cost $11.93 Unrealized
SERES THERAPEUTICS INC 0.3%
Value ($000) $2,075 Shares 50,000 Est. Cost $41.50 Unrealized
AQUINOX PHARMACEUTICALS INC 0.3%
Value ($000) $1,943 Shares 279,900 Est. Cost $12.15 Unrealized
AGILE THERAPEUTICS INC 0.2%
Value ($000) $1,564 Shares 182,053 Est. Cost $8.82 Unrealized
VCYT VERACYTE INC 0.2%
Value ($000) $1,537 Shares 137,990 Est. Cost $7.94 Unrealized +23.9%
CELLECTAR BIOSCIENCES INC 0.2%
Value ($000) $1,526 Shares 530,000 Est. Cost $2.22 Unrealized
NANOSTRING TECHNOLOGIES INC 0.2%
Value ($000) $1,234 Shares 80,000 Est. Cost $20.65 Unrealized
CONTRAFECT CORP 0.2%
Value ($000) $1,231 Shares 234,406 Est. Cost $5.25 Unrealized
PVCT PROVECTUS BIOPHARMACEUTICALS 0.2%
Value ($000) $1,188 Shares 2,200,000 Est. Cost $0.82 Unrealized 0.0%
ASND ASCENDIS PHARMA A S 0.1%
Value ($000) $1,087 Shares 61,500 Est. Cost $17.35 Unrealized
AKBA AKEBIA THERAPEUTICS INC 0.1%
Value ($000) $1,032 Shares 100,300 Est. Cost $24.08 Unrealized -64.6%
BIOTIE THERAPIES OYJ 0.1%
Value ($000) $999 Shares 50,000 Est. Cost $19.98 Unrealized
SCYNEXIS INC 0.1%
Value ($000) $873 Shares 99,366 Est. Cost $8.02 Unrealized
GALT GALECTIN THERAPEUTICS INC 0.1%
Value ($000) $781 Shares 286,200 Est. Cost $13.23 Unrealized -77.2%
PROVECTUS BIOPHARMACEUTICALS 0.1%
Value ($000) $480 Shares 2,200,000 Est. Cost $0.22 Unrealized
ADAPY ADAPTIMMUNE THERAPEUTICS PLC 0.1%
Value ($000) $458 Shares 25,000 Est. Cost $18.32 Unrealized
CELLECTAR BIOSCIENCES INC 0.1%
Value ($000) $413 Shares 530,000 Est. Cost $0.60 Unrealized
CLLS CELLECTIS S A 0.1%
Value ($000) $408 Shares 11,300 Est. Cost $34.60 Unrealized
APPLIED GENETIC TECHNOL CORP 0.0%
Value ($000) $262 Shares 17,110 Est. Cost $23.10 Unrealized
CELSUS THERAPEUTICS PLC 0.0%
Value ($000) $166 Shares 286,508 Est. Cost $5.99 Unrealized